Mergers and acquisitions – Page 13

News
Dow to sell nitroalkenes unit for $1.2bn

2014-11-14T00:00:00Z

Private equity firm Golden Gate Capital will buy Angus Chemical subsidiary
Business
Labcorp to buy Covance and enter contract research

2014-11-12T00:00:00Z

Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
Business
Perrigo to buy Omega Pharma for €3.6bn

2014-11-11T00:00:00Z

Deal strengthens Perrigo’s over-the-counter portfolio and pushes strongly into Europe
Business
Platform to expand in agrochemicals by buying Arysta

2014-10-29T00:00:00Z

Business will be integrated with previous acquisitions for a broad crop protection portfolio
Business
AbbVie backs out of Shire deal

2014-10-17T00:00:00Z

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits
Business
Endo outbids QLT for Auxilium merger

2014-10-10T00:00:00Z

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo
Business
US tax changes ripple into merger deals

2014-10-08T00:00:00Z

Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
Business
Actavis boosts antibiotics with Durata buyout

2014-10-08T00:00:00Z

$820 million deal gives Actavis control of newly-approved intravenous antibiotic
Business
Becton Dickinson to buy CareFusion for $12bn

2014-10-07T00:00:00Z

Medical devices merger continues consolidation trend
Business
J&J to buy antiviral specialist Alios

2014-10-01T00:00:00Z

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
Business
Mitsubishi to buy Japanese gases specialist

2014-09-30T00:00:00Z

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
Business
Lumara splits and sells to AMAG and Perrigo

2014-09-30T00:00:00Z

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
Business
Merck KGaA to buy Sigma–Aldrich

2014-09-26T00:00:00Z

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development
Business
Bayer to sever polymer arm

2014-09-23T00:00:00Z

German chemical giant’s exit from the materials world will help fund its crop and healthcare ambitions
Business
Eastman snaps up Taminco for $2.8bn

2014-09-12T00:00:00Z

Purchase will strengthen Eastman in niche markets and offers cost savings
Business
Roche to buy InterMune for respiratory boost

2014-08-29T00:00:00Z

$8.3bn deal gives Roche a leading position in pulmonary fibrosis
Business
Clinical collaborations drive cancer immunotherapy

2014-08-27T00:00:00Z

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
Business
Illumina targets cancer diagnostics

2014-08-22T00:00:00Z

Sequencing will improve tests and speed up clinical trials processes for big pharma partners
Business
Sanofi snaps up inhaled insulin licence

2014-08-12T00:00:00Z

Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
Business
AstraZeneca stocks respiratory and cancer pipelines

2014-07-31T00:00:00Z

A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company